| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/07/1992 | US5128135 Percutaneous or trans-mucosal absorption enhancers, preparations containing the enhancers, and a method of preparing thereof |
| 07/07/1992 | US5128132 Eriodictyon compositions and methods for treating internal mucous membranes |
| 07/07/1992 | US5128124 Administration of norethistereone-17-acetate |
| 07/07/1992 | CA1304687C Utilization of the "gel" pharmaceutical form containing n-(2.6-dichloro-m-tolil)-anthranilic acid (mechlophenamic acid) utilizable in therapy for topical usage |
| 07/07/1992 | CA1304686C Pharmaceutical composition containing cimetidine |
| 07/07/1992 | CA1304685C Pharmaceutical composition containing cimetidine |
| 07/07/1992 | CA1304684C Controlled release pharmaceutical composition |
| 07/07/1992 | CA1304681C Stable biologically active fluorochemical emulsions |
| 07/04/1992 | WO1992011845A1 Method for production of solid pharmaceutical preparation |
| 07/04/1992 | WO1992011844A1 Stabilization of proteins by cationic biopolymers |
| 07/04/1992 | CA2100272A1 Method for production of solid pharmaceutical preparation |
| 07/04/1992 | CA2099376A1 Stabilization of proteins by cationic biopolymers |
| 07/02/1992 | DE4038887A1 Verfahren zur herstellung von kollagenpartikeln und ihre verwendung als wirkstofftraeger A process for the production of collagen particles and their use as wirkstofftraeger |
| 07/01/1992 | WO1992012234A1 Dried, rotary disc fatty acid microencapsulated bacteria |
| 07/01/1992 | EP0493362A2 Compositions and kits for the treatment of oral diseases |
| 07/01/1992 | EP0493151A1 Slimming composition containing ginkgo biloba as alpha-2 blocker |
| 07/01/1992 | EP0492930A2 Transdermal delivery of dobutamine |
| 07/01/1992 | EP0492747A2 Pharmaceutical preparation for topical application |
| 07/01/1992 | EP0492707A2 Hydrophilic form of perfluoro compounds and method of manufacture |
| 07/01/1992 | EP0492247A1 Effervescent H2 blocker formulation |
| 07/01/1992 | EP0492235A1 Low moisture cholestyramine composition |
| 07/01/1992 | EP0492164A1 Therapeutic agent for glaucoma containing 2-phenyl-3-oxo-2H-1,4-benzothiazine derivatives |
| 07/01/1992 | EP0492007A1 Process for producing liquid loaded powders |
| 07/01/1992 | EP0491911A1 A controlled-release pharmaceutical composition for the oral use containing non steroidal anti-inflammatory drugs |
| 07/01/1992 | EP0491897A1 Liquid oral pharmaceutical compositions having anti-inflammatory activity |
| 07/01/1992 | EP0491853A1 Transdermal delivery device having delayed onset |
| 07/01/1992 | EP0491833A1 Vaccines |
| 07/01/1992 | EP0491754A1 Magnesium carbonate and oil tableting aid |
| 07/01/1992 | EP0491685A1 Lung cancer hyperthermia via ultrasound and/or convection with perfluorocarbon liquids |
| 07/01/1992 | EP0473645A4 Insect repellant |
| 07/01/1992 | EP0362270B1 Steroid lotion |
| 07/01/1992 | EP0308436B1 New medicated ointment, process for its production, means of application using said ointment and production of said ointment |
| 07/01/1992 | EP0256090B1 Solubilization of hydrophobic materials using lysophospholipid |
| 07/01/1992 | EP0179858B1 Antacid composition |
| 07/01/1992 | CN1062291A Pharmaceutical agents |
| 07/01/1992 | CN1062288A Bioadhesive composition and patch |
| 06/30/1992 | US5126331 Skin disorders |
| 06/30/1992 | US5126328 Heating aqueous mixture containing sugar, salts and gelatin yields boiling water-insoluble solids |
| 06/30/1992 | US5126324 Method of enhancing growth in patients using combination therapy |
| 06/30/1992 | US5126147 Sustained release dosage form |
| 06/30/1992 | US5126146 Cellulosic coating |
| 06/30/1992 | US5126145 Controlled release tablet containing water soluble medicament |
| 06/30/1992 | US5126144 Apparatus delivering nitroglycerin to the skin, process for the production thereof and use thereof |
| 06/30/1992 | US5126142 Dispenser comprising ionophore |
| 06/30/1992 | US5126135 Dermatological composition based on an aqueous phase |
| 06/30/1992 | US5126127 Stabilized PVP-I solutions |
| 06/30/1992 | US5126123 Aerosol drug formulations |
| 06/30/1992 | CA1304296C Percutaneous-administration-type pharmaceutical preparation of nitroglycerin |
| 06/30/1992 | CA1304294C Pharmaceutical preparations with extended release |
| 06/25/1992 | WO1992010997A1 Flavor stable zinc acetate compositions for oral absorption |
| 06/25/1992 | WO1992010287A1 Method of producing collagen particles, and the use of such particles as substrates for active substances |
| 06/25/1992 | WO1992010285A1 Microcapsule having temperature-dependent permeability profile |
| 06/25/1992 | WO1992010211A1 Pharmaceutical formulations |
| 06/25/1992 | WO1992010203A1 A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis |
| 06/25/1992 | WO1992010195A1 Cell proliferation matrix and use thereof |
| 06/25/1992 | WO1992010175A1 Lyophilized amino acid compositions containing glutamine |
| 06/25/1992 | WO1992010171A1 New pharmaceutical formulations containing a pharmacologically active ionizable substance as well as process for the preparation thereof |
| 06/25/1992 | WO1992010169A1 Method for the manufacture of a controlled release solid unit dosage form |
| 06/25/1992 | WO1992010164A1 Agent for reducing the growth of, or removing, human body hair |
| 06/25/1992 | DE4041563A1 Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren Process for the preparation of active compound-microparticle of hydrolytically degradable polymeric |
| 06/25/1992 | CA2097181A1 Cell proliferation matrix and use thereof |
| 06/24/1992 | EP0491076A1 Penetration enhancement with multi-component system of N-aliphatic pyrrolidones with lower alcohols |
| 06/24/1992 | EP0490944A1 Transmucosal dosage form. |
| 06/24/1992 | EP0490920A1 Pharmaceutical preparation binding with gastric acid. |
| 06/24/1992 | EP0490917A1 Contrast media |
| 06/24/1992 | EP0490916A1 Compositions and methods of manufacture of oral dissolvable medicaments. |
| 06/24/1992 | EP0402369A4 Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone |
| 06/24/1992 | CN1062087A Preparing technology for new decoction |
| 06/24/1992 | CN1062083A Fineness treatment of traditional chinese medicine and method for extracting injections |
| 06/23/1992 | WO1992011000A1 Method of producing microscopic particles made of hydrolytically decomposable polymers and containing active substances |
| 06/23/1992 | US5124421 Addition polymers crosslinked with N,O-dimethacryloylhydroxylamine; oral drug delivery; sustained release in the duodenum |
| 06/23/1992 | US5124392 Administering a steroid |
| 06/23/1992 | US5124352 Cardiovascular disorders |
| 06/23/1992 | US5124320 An external analgesic lotion containing active ingredients of camphor and menthol and method of making such lotion |
| 06/23/1992 | US5124318 Hermetic sealed container |
| 06/23/1992 | US5124317 Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
| 06/23/1992 | US5124315 Liquid pharmaceutical composition for nasal administration containing a polypeptide as active ingredient |
| 06/23/1992 | US5124158 Applying 2-pyridylmethylthio- and sulfinyl-benzimidazoles |
| 06/23/1992 | US5124157 Using adhesive skin patch |
| 06/23/1992 | US5124156 Lysozyme of egg white and mace extract |
| 06/23/1992 | US5124155 Intraocular surgery; water swellable gel |
| 06/23/1992 | US5124154 Aminosteroids for ophthalmic use |
| 06/23/1992 | US5124152 Parenteral formulation of metolazone |
| 06/23/1992 | US5124151 Controlling ph |
| 06/23/1992 | US5124081 Amphiphilic lipid compounds, process for their preparation and their applications especially in cosmetics and dermopharmacy |
| 06/23/1992 | US5123900 Moisture permeable double disk |
| 06/23/1992 | US5123414 Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
| 06/23/1992 | CA1303999C Filtrating cosmetic composition in the form of an oil-in-water emulsion comprising a uv-a and a uv-b filter and its use for protecting the skin against ultra-violet rays |
| 06/23/1992 | CA1303998C Transparent cosmetic composition reflecting infrared rays and its use for theprotection of human skin against infrared rays |
| 06/23/1992 | CA1303996C Methods for treatment of sundamaged human skin with retinoids |
| 06/23/1992 | CA1303993C Pharmaceutical compositions containing ranitidine |
| 06/23/1992 | CA1303992C Stable injectable solutions of vinca dimer salts |
| 06/23/1992 | CA1303990C Solubilization of hydrophobic materials using lysophospholipids |
| 06/23/1992 | CA1303978C Injectable opacifying composition containing liposomes of high encapsulation capacity for x-ray examinations |
| 06/22/1992 | WO1992011190A2 Device for delivering an aerosol |
| 06/22/1992 | CA2055661A1 Treatment of upset stomach associated with heartburn, sour stomach or acid indigestion with an effervescent h2 blocker formulation |
| 06/21/1992 | WO1992011120A1 Method and apparatus for granulation |
| 06/21/1992 | CA2098600A1 Method and apparatus for granulation |
| 06/21/1992 | CA2057647A1 Transdermal delivery of dobutamine |
| 06/21/1992 | CA2047453A1 Low moisture cholestyramine composition |